Skip to main content

Lifeward Ltd.

For the period ended Dec 31, 2025. Filed Mar 18, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 18, 2026

LFWD$5.85-1.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 8. Consolidated Statements of Cash Flows

CONSOLIDATED STATEMENTS OF CASH FLOWS

Year ended December 31,
202520242023
Cash flows used in operating activities:
Net loss$(19,914)$(28,942)$(22,133)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation333494239
Amortization of intangible assets-3,3471,608
Impairment of intangible and tangible assets2,7839,794-
Share-based compensation7431,2811,328
Remeasurement of earnout liability(608)(2,684)(315)
Accrued interest442-(11)
Change in fair value of derivative liability(197)--
Exchange rate fluctuations(110)(34)(45)
Changes in assets and liabilities:
Trade receivables, net(134)(2,884)(311)
Prepaid expenses and other assets192188(656)
Operating lease right-of-use assets4391,195125
Inventories896(920)(277)
Trade payables(347)(47)1,037
Employees and payroll accruals110(702)(14)
Deferred revenues(419)(438)(269)
Operating lease liabilities(731)(1,216)(144)
Other liabilities(304)(150)(829)
Net cash used in operating activities(16,826)(21,718)(20,667)
Cash flows used in investing activities:
Acquisition of a business, net of cash acquired--(18,068)
Purchase of property and equipment(16)-(81)
Net cash used in investing activities(16)-(18,149)
Cash flows used in financing activities:
Issuance of ordinary shares in a Registered Direct offering, net of issuance expenses in the amount of $558 (1)4,442--
Issuance of ordinary shares under at-the-market offering, net of issuance costs of $192 (1)2,578--
Issuance of ordinary shares in a public offering, net of issuance expenses in the amount of $432 (1)2,183--
Purchase of treasury shares--(992)
Proceeds from short term loan1,437--
Proceeds from bifurcated embedded derivatives1,563--
Net cash provided by (used in) financing activities12,203-(992)
Effect of Exchange rate changes on Cash, Cash Equivalents and Restricted Cash1103445
Decrease in cash, cash equivalents, and restricted cash(4,529)(21,684)(39,763)
Cash, cash equivalents, and restricted cash at beginning of period7,10828,79268,555
Cash, cash equivalents, and restricted cash at end of period$2,579$7,108$28,792

(1) See Note 8b to the condensed consolidated financial statements.

F - 8

CONSOLIDATED STATEMENTS OF CASH FLOWS

Year ended December 31,
2025 · 2024 · 2023
Supplemental disclosures of non-cash flow information
Classification of inventory to property and equipment, net$35$404$481
Expenses related to offerings not yet paid (1)$473$-$-
ROU assets obtained from lease liabilities$1,435$193$513
Supplemental disclosures of cash flow information:
Cash paid (received) for income taxes$36$(7)$126
Cash received from interest$81$6541,341
Reconciliation of cash, cash equivalents and restricted cash as shown in the consolidated statements of cash flows
Cash and cash equivalents$2,169$6,746$28,083
Restricted cash$410$362$709
Total Cash, cash equivalents, and restricted cash$2,579$7,108$28,792

(1) See Note 8b to the condensed consolidated financial statements

F - 9

**LIFEWARD LTD. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

U.S. dollars in thousands

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.